ImCheck Therapeutics

Description: ImCheck Therapeutics develops innovative immunotherapy antibodies targeting γ9δ2 T cells & butyrophilins for superior cancer treatment.

Country: France

Based in: Marseille, Provence-Alpes-Cote d'Azur

Founded: 2015

Funding Stage: Series A/B

Tags: ['Biopharma', 'Biotechnology', 'Health Care', 'Life Science', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.